# Gastroenterology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Natsume Sōseki (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET023-SYN-TD
- Date: 1910-05-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Kenji Abrahamsen-Ito, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Haruka Lindqvist-Mori, MD

## Reason for consultation

Suspected bleeding peptic ulcer in a 43-year-old novelist with three weeks of epigastric pain, two black, tarry stools ten days ago, and iron-deficiency anemia, after occasional ibuprofen. Please perform upper endoscopy with biopsy, exclude gastric cancer, test for Helicobacter pylori, and advise on treatment and follow-up. **S**

## History

Mr. Natsume, a 43-year-old novelist, is seen at the request of Dr. Lindqvist-Mori three days after his first visit. He describes three weeks of gnawing upper abdominal pain before meals and at night, relieved by food, and two black, tarry stools about two weeks ago, with none since. He had taken ibuprofen for headaches a few times a month and stopped it at his first visit. He has not vomited blood, lost weight, or had trouble swallowing. He does not smoke and rarely drinks. He has never had an endoscopy. He is worried about stomach cancer and wants to keep writing his newspaper serial. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert after light sedation; pale; pulse 82, blood pressure 122/76 |
| Abdomen | Mild epigastric tenderness; no guarding, mass or enlarged liver |
| Lymph nodes | No supraclavicular node |

BP 122/76 mmHg; pulse 82 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 51.8 kg; BMI 20.5 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Lindqvist-Mori's intake note and results: hemoglobin 11.2 g/dL with MCV 76 fL and ferritin 8 ng/mL; urea nitrogen 15 mg/dL; Glasgow-Blatchford score 4. Hemoglobin this morning 11.0 g/dL. Upper endoscopy this morning under light sedation: normal esophagus; a 15 mm ulcer on the lesser curvature at the angulus with a clean white base and no visible vessel or adherent clot (Forrest III), regular margins and smooth converging folds; open-type atrophy (Kimura-Takemoto O-1) with antral nodularity; no blood in the stomach; normal duodenum. Six biopsies were taken from the ulcer margin, five mapping biopsies (updated Sydney protocol) for histology, and a biopsy for clarithromycin-resistance PCR. Rapid urease test positive. Hemoglobin: 11 g/dL (low). All results are synthetic.

## Assessment

1. **Gastric ulcer with recent bleeding** (K25.4). The source is a 15 mm gastric ulcer at the angulus with a clean base, which carries a low risk of rebleeding and needs no endoscopic treatment. The likely causes are Helicobacter pylori and the ibuprofen. With a stable hemoglobin and normal pulse and blood pressure, he can be treated at home. The ulcer looks benign, but a gastric ulcer must be biopsied and followed to healing because an early gastric cancer can look like one. **S**
2. **Helicobacter pylori infection** (B96.81). The rapid urease test is positive. Clarithromycin resistance is common in Japan, so the regimen should follow the PCR result: vonoprazan, amoxicillin and clarithromycin for 7 days if the strain is susceptible, or vonoprazan 20 mg twice daily with amoxicillin 1 g three times daily for 14 days if it is resistant. Bismuth quadruple therapy, preferred elsewhere when susceptibility is unknown, is not available for this use in Japan. **S**
3. **Iron-deficiency anemia** (D50.0). Explained by the bleeding ulcer. In an adult man with iron-deficiency anemia a colonoscopy is usually advised too, but with an upper source found and no bowel symptoms it can wait to see whether the anemia corrects once the ulcer heals; if it does not, colonoscopy is needed. **S**
4. **Gastric cancer risk**. The open-type atrophy at endoscopy suggests long-standing infection; the mapping biopsies will stage atrophy and intestinal metaplasia. Eradication lowers the risk of gastric cancer but does not remove it when atrophy is extensive, so surveillance endoscopy is likely to be needed. **S**

## Recommendations

1. Start vonoprazan 20 mg each morning now, after the biopsies, and continue for eight weeks for a gastric ulcer.
2. No NSAIDs, including aspirin and combination cold remedies; acetaminophen for pain; no smoking and little alcohol.
3. Eradication at the two-week visit, chosen by the clarithromycin-resistance PCR: vonoprazan-amoxicillin dual therapy for 14 days if resistant, or vonoprazan triple therapy with clarithromycin for 7 days if susceptible.
4. Confirm eradication with a 13C urea breath test at least four weeks after the antibiotics and at least two weeks after stopping vonoprazan.
5. Repeat endoscopy at about ten weeks to confirm healing and to biopsy the scar.
6. Oral iron from today; colonoscopy only if the anemia does not correct after the ulcer has healed.
7. Endoscopic surveillance after eradication if the biopsies confirm atrophy or intestinal metaplasia: yearly is usual practice in Japan for moderate or extensive atrophy.
8. Call 119 or go to the emergency department for black, tarry stools, vomiting blood or coffee-ground material, fainting, or sudden severe pain.

## Strengths and supports

- Supports: his family, his students and friends, and his work **S**

## Communication

Discussed with Dr. Lindqvist-Mori the same morning; she continues the prescribing, the iron and the follow-up. The endoscopy pictures were shown to Mr. Natsume, who asked whether it was cancer; he was told that the ulcer looks benign and that the biopsies would answer the question in about two weeks. **S**

## Follow-up

Repeat endoscopy with Dr. Abrahamsen-Ito at about ten weeks, combined with the urea breath test; then yearly surveillance endoscopy if the histology confirms atrophy. **S**

## Guideline basis

- ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024), American College of Gastroenterology (Am J Gastroenterol 2024;119(9):1730-1753)
- Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022), European Helicobacter and Microbiota Study Group (Gut 2022;71(9):1724-1762)
- Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)), Japanese Society for Helicobacter Research (Helicobacter 2019;24(4):e12597)
- Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026), Japanese Society of Gastroenterology (J Gastroenterol 2026;61(10):1361-1381)
- ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021), American College of Gastroenterology (Am J Gastroenterol 2021;116(5):899-917)
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge
